vs
Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and DIODES INC (DIOD). Click either name above to swap in a different company.
CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $391.6M, roughly 1.2× DIODES INC). DIODES INC runs the higher net margin — 2.6% vs -10.1%, a 12.7% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 15.4%). DIODES INC produced more free cash flow last quarter ($12.4M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 13.9%).
Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.
Diodes Incorporated is a global semiconductor manufacturer that designs, produces and supplies discrete, analog and mixed-signal semiconductor products. Its solutions serve key end markets including automotive, industrial, consumer electronics, personal computing and communications infrastructure, with a worldwide customer base.
CLOV vs DIOD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $487.7M | $391.6M |
| Net Profit | $-49.3M | $10.2M |
| Gross Margin | — | 31.1% |
| Operating Margin | -10.1% | 3.4% |
| Net Margin | -10.1% | 2.6% |
| Revenue YoY | 44.7% | 15.4% |
| Net Profit YoY | -123.2% | 23.8% |
| EPS (diluted) | — | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $487.7M | $391.6M | ||
| Q3 25 | $496.6M | $392.2M | ||
| Q2 25 | $477.6M | $366.2M | ||
| Q1 25 | $462.3M | $332.1M | ||
| Q4 24 | $337.0M | $339.3M | ||
| Q3 24 | $331.0M | $350.1M | ||
| Q2 24 | $356.3M | $319.8M | ||
| Q1 24 | $346.9M | $302.0M |
| Q4 25 | $-49.3M | $10.2M | ||
| Q3 25 | $-24.4M | $14.3M | ||
| Q2 25 | $-10.6M | $46.1M | ||
| Q1 25 | $-1.3M | $-4.4M | ||
| Q4 24 | $-22.1M | $8.2M | ||
| Q3 24 | $-9.2M | $13.7M | ||
| Q2 24 | $7.4M | $8.0M | ||
| Q1 24 | $-19.2M | $14.0M |
| Q4 25 | — | 31.1% | ||
| Q3 25 | — | 30.7% | ||
| Q2 25 | — | 31.5% | ||
| Q1 25 | — | 31.5% | ||
| Q4 24 | — | 32.7% | ||
| Q3 24 | 24.5% | 33.7% | ||
| Q2 24 | 30.3% | 33.6% | ||
| Q1 24 | 23.6% | 33.0% |
| Q4 25 | -10.1% | 3.4% | ||
| Q3 25 | -4.9% | 3.0% | ||
| Q2 25 | -2.2% | 2.6% | ||
| Q1 25 | -0.3% | 0.4% | ||
| Q4 24 | -6.4% | 3.5% | ||
| Q3 24 | -2.7% | 6.2% | ||
| Q2 24 | 2.0% | 1.2% | ||
| Q1 24 | -6.5% | 4.3% |
| Q4 25 | -10.1% | 2.6% | ||
| Q3 25 | -4.9% | 3.6% | ||
| Q2 25 | -2.2% | 12.6% | ||
| Q1 25 | -0.3% | -1.3% | ||
| Q4 24 | -6.6% | 2.4% | ||
| Q3 24 | -2.8% | 3.9% | ||
| Q2 24 | 2.1% | 2.5% | ||
| Q1 24 | -5.5% | 4.6% |
| Q4 25 | — | $0.23 | ||
| Q3 25 | — | $0.31 | ||
| Q2 25 | — | $0.99 | ||
| Q1 25 | — | $-0.10 | ||
| Q4 24 | — | $0.18 | ||
| Q3 24 | — | $0.30 | ||
| Q2 24 | — | $0.17 | ||
| Q1 24 | — | $0.30 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $78.3M | $377.0M |
| Total DebtLower is stronger | — | $25.7M |
| Stockholders' EquityBook value | $308.7M | $1.9B |
| Total Assets | $541.0M | $2.4B |
| Debt / EquityLower = less leverage | — | 0.01× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $78.3M | $377.0M | ||
| Q3 25 | — | $386.4M | ||
| Q2 25 | — | $327.3M | ||
| Q1 25 | — | $343.9M | ||
| Q4 24 | $194.5M | $316.1M | ||
| Q3 24 | $288.0M | $319.3M | ||
| Q2 24 | $254.8M | $273.9M | ||
| Q1 24 | $208.3M | $276.0M |
| Q4 25 | — | $25.7M | ||
| Q3 25 | — | $24.9M | ||
| Q2 25 | — | $26.4M | ||
| Q1 25 | — | $20.5M | ||
| Q4 24 | — | $20.7M | ||
| Q3 24 | — | $22.2M | ||
| Q2 24 | — | $20.3M | ||
| Q1 24 | — | $20.9M |
| Q4 25 | $308.7M | $1.9B | ||
| Q3 25 | $340.9M | $1.9B | ||
| Q2 25 | $344.2M | $1.9B | ||
| Q1 25 | $336.1M | $1.8B | ||
| Q4 24 | $341.1M | $1.8B | ||
| Q3 24 | $342.2M | $1.8B | ||
| Q2 24 | $324.9M | $1.8B | ||
| Q1 24 | $292.5M | $1.7B |
| Q4 25 | $541.0M | $2.4B | ||
| Q3 25 | $559.7M | $2.5B | ||
| Q2 25 | $575.0M | $2.5B | ||
| Q1 25 | $583.7M | $2.4B | ||
| Q4 24 | $580.7M | $2.4B | ||
| Q3 24 | $653.0M | $2.4B | ||
| Q2 24 | $674.2M | $2.4B | ||
| Q1 24 | $671.8M | $2.4B |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.01× | ||
| Q1 25 | — | 0.01× | ||
| Q4 24 | — | 0.01× | ||
| Q3 24 | — | 0.01× | ||
| Q2 24 | — | 0.01× | ||
| Q1 24 | — | 0.01× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-66.9M | $38.1M |
| Free Cash FlowOCF − Capex | $-69.0M | $12.4M |
| FCF MarginFCF / Revenue | -14.1% | 3.2% |
| Capex IntensityCapex / Revenue | 0.4% | 6.6% |
| Cash ConversionOCF / Net Profit | — | 3.74× |
| TTM Free Cash FlowTrailing 4 quarters | $-69.2M | $137.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-66.9M | $38.1M | ||
| Q3 25 | $12.1M | $79.1M | ||
| Q2 25 | $5.4M | $41.5M | ||
| Q1 25 | $-16.3M | $56.7M | ||
| Q4 24 | $34.8M | $81.8M | ||
| Q3 24 | $50.0M | $54.4M | ||
| Q2 24 | $44.8M | $14.4M | ||
| Q1 24 | $25.9M | $-31.1M |
| Q4 25 | $-69.0M | $12.4M | ||
| Q3 25 | $11.4M | $62.8M | ||
| Q2 25 | $4.8M | $21.1M | ||
| Q1 25 | $-16.5M | $40.8M | ||
| Q4 24 | $33.3M | $62.1M | ||
| Q3 24 | $49.6M | $39.4M | ||
| Q2 24 | $44.4M | $-3.5M | ||
| Q1 24 | $25.5M | $-51.5M |
| Q4 25 | -14.1% | 3.2% | ||
| Q3 25 | 2.3% | 16.0% | ||
| Q2 25 | 1.0% | 5.8% | ||
| Q1 25 | -3.6% | 12.3% | ||
| Q4 24 | 9.9% | 18.3% | ||
| Q3 24 | 15.0% | 11.2% | ||
| Q2 24 | 12.5% | -1.1% | ||
| Q1 24 | 7.3% | -17.1% |
| Q4 25 | 0.4% | 6.6% | ||
| Q3 25 | 0.1% | 4.2% | ||
| Q2 25 | 0.1% | 5.6% | ||
| Q1 25 | 0.0% | 4.8% | ||
| Q4 24 | 0.5% | 5.8% | ||
| Q3 24 | 0.1% | 4.3% | ||
| Q2 24 | 0.1% | 5.6% | ||
| Q1 24 | 0.1% | 6.7% |
| Q4 25 | — | 3.74× | ||
| Q3 25 | — | 5.54× | ||
| Q2 25 | — | 0.90× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 9.93× | ||
| Q3 24 | — | 3.95× | ||
| Q2 24 | 6.04× | 1.80× | ||
| Q1 24 | — | -2.22× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLOV
Segment breakdown not available.
DIOD
| Distributor | $253.1M | 65% |
| Direct Sales | $138.5M | 35% |
